Coastlands Capital LP Buys $319K of Bolt Biotherapeutics Inc (BOLT) — SEC Form 4, Nov 10, 2026

Open-Market Net Purchase · SEC Form 4

+$319,000

Equity position changed by +12.1%

Reporting Owner

Coastlands Capital LP

10%+

TXN 2026-11-09 · FILED 2026-11-10

Equity Position 462K sh 412,416 → 462,416

Equity Change +12.1% shares held after vs before

Filing Lag 1 business day within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Bolt Biotherapeutics Inc

BOLT CIK 0001641281

Reporting Owner

Name	Relationship
Coastlands Capital LP CIK 0002068530	10% Owner

Coastlands Capital LP at Bolt Biotherapeutics Inc Full insider history

Bought (12 mo) $319,000

Sold (12 mo) —

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1 F2	2026-11-09	P - Purchase	50,000 A	$6.38	+$319,000	462,416	Indirect By Coastlands Capital LP

Footnotes (2)

F1: The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $6.3618 to $6.4044. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the reporting persons will provide full information regarding the number of shares purchased at each separate price. Show more
F2: Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership"). Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 3 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Bolt Biotherapeutics Inc

GET /v1/forms/4/0001104659-26-125077 API docs